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Abstract: 
Immunosenescence contribute to increase the blood-brain barrier (BBB) permeability, leading 
cognitive impairment and neurodegeneration. Thus, we investigated the anti-inflammatory effect of 
exercise and taurine supplementation on peripheral markers of blood-brain barrier, inflammation, 
and cognition of elderly women. Forty-eight elderly women (83.58±6.9 years) participated in the 
study, and were allocated into combined exercise training (CET: n=13), taurine supplementation 
(TAU: n=12), exercise training associated with taurine (CET+TAU: n=11), or control group (CG: 
n=12). Exercise was applied twice a week (multi-modal exercise). Taurine ingestion was 1.5g., 
once a day. Participants were evaluated before and after 14-weeks of intervention. Plasma levels of 
IL-1β, IL-1ra, IL-6, IL-10, IL-17, TNF-α, and serum concentration of S100β and neuron specific 
enolase (NSE) were determined. The mini mental state examination (MMSE) was also applied. 
Concentrations of S100β were maintained in all intervention groups, while a subtle increase in the 
CG was found. NSE levels increased only in TAU group (p<0.05). CET reduced TNF-α, IL-6, and 
IL-1β/IL-1ra, IL-6/IL10, TNF-α/IL-10 ratios (p<0.05). TAU decreased the IL-1β/IL-1ra ratio 
(p<0.05). MMSE score increased only in CET+TAU group (p<0.05). Multiple regression analysis 
showed that there was a trend for changes in IL-1β and CCI to be independently associated with 
changes in S100β. Exercise and taurine decreased inflammation, and maintained the BBB integrity 
in elderly women. Exercise emerged as an important tool to improve brain health even when started 
at advanced ages. 
Key-words: aging; inflammation; supplementation; taurine; brain; cognition; 
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INTRODUCTION 
Chronic inflammation is involved in the pathophysiology of many neurodegenerative conditions 
(Cho et al. 2015). Related to the genesis and worsening of these is the increased blood-brain barrier 
(BBB) permeability, an endothelial structure which controls the influx and efflux of components 
between blood flow and central nervous system (CNS) (Abbott 2000). Low chronic systemic 
inflammation during aging, known as ‘inflammaging’, has been proposed to increase BBB 
permeability (Elwood et al. 2017), which has been measured through peripheral levels of neuronal-
derived proteins, such as S100β and neuronal-specific enolase (NSE) (Marchi et al. 2004, Sağ et al. 
2017). S100β protein is composed by two isometric subunits being expressed primarily by 
astrocytes and found predominately in astroglial and Scwann cells, while NSE is a 78kD gamma-
homodimer that represents the mainly enolase-enzyme found in neurons (Kanner et al. 2003, Haque 
et al. 2016). Quantitative measures of both biomarkers have been used to represent BBB 
permeability and neuronal damage in humans, respectively (Isgrò et al. 2015, Dadas et al. 2016). 
Epidemiological evidence has shown that physical activity can attenuate this age-related immune 
suppression and ameliorate health status in older participants (Beavers et al. 2010). Combined 
exercise training (CET) has demonstrated to be effective in increasing physical fitness and 
cognition (Vaughan et al. 2014). Nutritional therapy, such as supplementation with taurine, can also 
decrease inflammation in several pathological conditions (Marcinkiewicz and Kontny 2014). While 
it is one of the most abundant amino acids in the human body, taurine levels decrease with age 
(Redmond et al. 1998). Animal and human model shave shown that both exercise and 
supplementation with taurine have beneficial effects in modulating the Th1/Th2 cytokine balance 
and down-regulate the expression of pro-inflammatory mediators related to endothelial dysfunction 
(Marcinkiewicz and Kontny 2014, Chupel et al. 2017). However, the combination of exercise 
training and supplementation with taurine on inflammatory parameters have not yet been 
investigated in older subjects. The purpose of the present study was to examine the effect of both 
exercise and taurine, administrated in combination and isolated on peripheral markers of BBB 
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dysfunction, inflammatory balance, and cognition in older women. It is expected that exercise and 
supplementation with taurine will lead to a decrease in peripheral markers of BBB permeability, 
together with an improvement of an anti-inflammatory environment and increase in cognition. 
MATERIALS AND METHODS 
Study Design 
This was a naturalistic, prospective, controlled trial (treatment vs care as usual). All subjects 
volunteered to participate in exercise classes or supplementation programs. The sample size was 
estimated using adjusted ANOVA for repeated measures effects using the G*Power software 
(version 3.1.9.2). Alpha (type I error rate) was set at 0.05, and power (type II error rate) at 0.85 with 
the inclusion of forty participants revealing sufficient power. 
Participants 
Forty-eight older women (83.5±6.9 year old) participated in the study and were allocated into four 
groups: a combined exercise training (CET: n=13), supplementation with taurine (TAU: n=12), a 
group undergoing CET plus supplementation (CET+TAU: n=11), and a control group receiving 
care as usual (CG: n=12). Details of the experiment design are presented in Figure 1 and the 
participants characteristics are shown in Table 1. All of them completed and signed an informed 
consent form prior to their enrolment in the study. After obtaining this consent, data was collected 
regarding biosocial, global health and general medical history with the medical staff of the nursing 
home. To be eligible for the study, participants needed to fulfil the following criteria: being a 
woman living in a nursing home support centre; age > 60 years; capacity to practice exercise 
without causing harm to themselves with approval of the medical department. Based on the initial 
assessment, we excluded volunteers with history of recent head trauma, uncontrolled diabetes 
mellitus and hypertension, current chronic renal, liver or respiratory disorders, neurologic disorders 
or those with severe cognitive impairment according to the cut-off Mini Mental State Examination 
criteria (MMSE) (≤ 9 points), recent myocardial infarction or stroke (within the previous 6 months). 
We also excluded those individuals who were on hormone replacement therapy. Individuals with 
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unstable medical conditions, highlighted by starting new medications within the data collection 
period were also excluded. The remaining subjects were allowed to continue using their usual 
prescribed medication (use of furosemide, valsartan, fluoxetine and alprazolam occurred). 
Comorbidities are present among the sample such as: hypertension (75%), heart failure (58%) and 
dyslipidaemia (34%).   This study was approved by the Faculty of Sport Science and Physical 
Education– University of Coimbra Ethical Committee, and conducted according to the Declaration 
of Helsinki guidelines on research in humans. 
Experimental Design 
All participants in the study lived in the same institution, and were evaluated before and after 14 
weeks of intervention. CET was applied twice a week and the classes took place inside the nursing 
room gym, on nonconsecutive days, during fourteen weeks. The TAU group was supplemented 
during the same period. CET+TAU associated both interventions (exercise + supplementation), and 
the CG did not follow any type of exercise program during 14 weeks but received care as usual. 
Experimental Procedures 
Exercise 
The development of the combined exercise training program (CET) was conducted by specialists in 
exercise prescriptions for the older population. The method designed for the CET program followed 
the recommendations of the American College of Sport Medicine/American Heart Association for 
the organization of exercise interventions (Nelson et al. 2007). To be safe for an older population, 
CET was a chair-based exercise program. The duration of each class was 60 minutes involving six 
minutes of warm-up, forty-eight minutes consisting of a main part and six minutes of cool-down. 
CET classes comprised resistance exercise and aerobic/cardiovascular training. Two sessions of 
pre-intervention familiarization occurred to adapt participants to the resistance training which 
involved the major muscle groups, and was performed by a predetermined number of exercises that 
ranged from 4-8 activities, 2-3 sets with15-20 repetitions. The cadence of execution was 2:2 and 
rest between sets ranged from 30-45 seconds (example of activities: front squat, unilateral hip 
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flexion, bench over row, chest press, standing reverse fly, spine twist extension arm, shoulder 
press/twist arm front position, frontal total raiser, biceps arm curl stand/chair, overhead triceps 
exertion). The aerobic/cardiovascular component was held in series using 4-8 chair-based exercises 
and walking around the room (with and without obstacles). Exercises included simulated walking, 
walking around the gym-room, hip marching, chair-stand and upper body twist, standing rear leg 
extension, step heel, and kicks in a seated position. The CET program was divided into two 
microcycles (microcycle1 during the first seven weeks; microcycle2 the remaining weeks). 
Resistance training progressed within microcycles using decreased rest between sets, increased time 
of muscle contraction, and use of more complex progressions in exercises, while in the aerobic part 
walking with obstacles and with changes of direction were introduced. The participants did the 
resistance training using the yellow color elastic-band (TheraBand, Hygenic Corporation, Akron, 
OH, USA). The exercise intensity was measured using the OMNI perceived exertion scale (PES), 
which consisted of a scale ranging from 0 to 10 points concerning the quality of efforts:(0) 
extremely (1-2) easy, (3-5) somewhat easy, (6-7) somewhat-hard; (8) hard (9-10) extremely-hard). 
The intensity was kept within values of PES, ranging from 5 to 7 points. In addition, exercise 
intensity was monitored using heart rate monitors (Polar, 810), which were randomly distributed 
between the participants during the exercise program to record any abnormal alterations on heart 
rate and to avoid cardiovascular risk. No music was used during the exercise classes. 
Supplementation 
Taurine was supplied by LaborSpirit LTDA, (Portugal). The dosage used was 1.5g, which is well 
tolerated and safe for humans, and has been shown effective in decreasing inflammation and 
improving cardiac function in older people (Shao and Hathcock 2008, Ahmadian et al. 2017). 
Taurine was diluted in 150 mL of drinking water once a day during 14 weeks. Supplementation was 
given every day in the morning, and subjects of both supplement (TAU and CET+TAU) groups 
received the supplementation at the same time of the day. In the days when there were CET sessions 
supplementation was ingested at least 30 minutes before the session. In total, each subject received 
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98 doses of 1.5g of taurine over a period of 14 weeks. Only the principal researcher and the staff of 
the nursing home had access to the supplement. The caregivers were responsible to dilute the 
powder in water and give it to the subjects, recording when the supplemented was ingested. The 
staff was oriented regarding the correct administration of the supplement, clarification of doubts 
concerning their use, and to stop the procedure in the presence of any adverse side-effect. 
Data Collection 
All baseline evaluations were performed during the morning, two weeks before the beginning of the 
interventions. Evaluations occurred on separated days, beginning with the assessments of the 
anthropometric measures, the cognitive profile, and the hand-grip test. Collection of blood samples 
was done on a separate day by a registered nurse. The participants were warned two days in 
advance for the need to wear appropriate clothes, to avoid ingestion of alcohol and caffeine, and to 
maintain their sleeping habits. All data collection was done by a staff member and an assistant, and 
took place individually in a separate and quiet room (with adequate light and temperature) to 
maintain the participants’ privacy. To avoid interference of tester variability in data collection, each 
participant was always evaluated by the same staff members at the same time of day. 
Global Health 
In order to determine the presence of comorbidities in participants, all data regarding global health 
were obtained by interview from the medical department of the social and health care instituteand 
by applying the Charlson Comorbidity Index (CCI). Based on 17 comorbid conditions, this index is 
reported to be able to predict 1 to 10-year mortality risk (Charlson et al. 1994). 
Anthropometric Measures 
Body mass was determined using a portable scale (Seca, model 770, Germany) with a precision of 
0.1 kilograms. A retractable glass fiber tape (Hoechstmass-Rollfix, Germany) was used to measure 
the waist circumference and stature was determined using a portable stadiometer (SecaBodymeter, 
model 208, Germany) with 0.1 centimeters of precision. 
Nutritional Assessment 
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The mini nutritional assessment (MNA) was used to evaluate the nutritional status, and was fulfilled 
by the participant together with the nursing staff. It is composed by a total of 18 items and the score 
ranges from 0 to 30. The MNA was used to classify the nutritional status of the elderly among a 
state of protein-energy malnutrition (< 17 points), risk of malnutrition (between 17 and 23.5 points), 
and satisfactory nutritional status (> 23.5 points) (Guigoz et al. 1996). Additionally, we consulted 
the nutritionist menus developed for the nursing home, to verify the amount of macronutrients 
intake during the intervention. 
Cognitive Assessment 
The evaluation of cognitive function was made using the Mini Mental State Examination (MMSE). 
The MMSE is a 30-point scale instrument that assesses five areas of cognition: orientation, 
immediate recall, attention and calculation, delayed recall, and language (Folstein et al. 1975). It is 
used to classify individuals by cognitive profile, as: [0-9] severe cognitive impairment; [10-18] 
moderate cognitive impairment; [19-24] mild cognitive impairment; [25-30] normal cognitive 
profile. The validated Portuguese version was used (Morgado et al. 2009). 
Hand-Grip Strength Test (HGT) 
Hand-Grip strength was measured using a dynamometer with registration in kilograms (Lafayette, 
78010, Indiana, USA). The participant was in a standing position with the elbows positioned at the 
side of the body. The handle was appropriately regulated to their hand size. When ready, the subject 
squeezed the dynamometer with maximum isometric effort, which was maintained during five 
seconds. Thirty seconds of rest between measurements for both hands were given. The test was 
performed twice. The best value of each hand was computed and the higher value obtained was 
used. 
Blood Collection and Analyses 
Blood samples were collected during the morning (from 10 a.m. to 11 a.m.) by venipuncture, after 
fifteen minutes of rest, at baseline and after fourteen weeks. All the subjects were encouraged to 
avoid strenuous physical efforts in the two days prior to the blood collection. Samples were drawn 
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into vacutainer tubes containing EDTA for plasma and gel separator for serum analytics. After 
processing, plasma and serum were aliquoted into eppendorfs and stored at -80°C until 
determination of the plasma concentrations of IL-1β, IL-1ra, IL-6, TNF-α, IL-10 (Invitrogen, CA) 
and IL-17 (R&D Systems, UK) by ELISA. Serum samples were used to determination of peripheral 
markers of BBB permeability, S100β and neuronal specific enolase (NSE) concentrations, by 
ELISA (Biovendor Laboratory Medicine, Czech Republic and R&D Systems, UK, respectively). 
Samples were run in duplicate and diluted when appropriate according to the manufacturer 
instructions. The intra-assay coefficient of variability was 2.7% for IL-1β, 3.2% for IL-1ra, 4.9% 
for TNF-α, 5.3% for IL-10, 2.3% for IL-17, 7.3% for S100β and 2.4% for NSE. The inter-assay CV 
was less than 10% for all biological analysis. 
Statistical Analyses 
Descriptive statistics were presented as mean ± standard deviation for all variables. Data were log-
converted to reduce bias arising from non-uniformity error. Analysis of variance using repeated 
measures ANOVA were performed to examine the response to the interventions. The within 
measures effect was time (before-after intervention) and between measures effect was treatment (4 
types). Bonferroni test was applied post hoc to detect differences between groups. The percent of 
change after the interventions was calculated ([postvalue/prevalue]-1) and a multiple regression 
analysis using interleukins changes (∆IL-1β, ∆IL-1ra, ∆IL-6, ∆IL-10, ∆IL-17 and ∆TNF-α), and 
baseline CCI was performed to explore their influence on changes in S100β over time. Those 
variables that did not contribute to the adjusted model were removed by stepwise backward 
analysis. The coefficient for each variable was obtained from the adjusted model with the lowest p 
value. Comparison between groups at baseline were performed using one-way ANOVA. 
Additionally, univariate analysis for within groups comparisons in were done using the student t-
tests for paired samples. To report the strength of the exercise interventions, the effect size (point-
biserial correlation, rpb) was calculated and converted to standardized Cohen’s d changes in means, 
categorized as trivial (d<0.2), small (d≥ 0.2 to ≤ 0.6), moderate (d≥ 0.6 to ≤ 1.2), large (d≥ 1.2 to ≤ 
Page 9 of 31
 
10 
2.0), very large (d≥ 2.0 to ≤ 4.0) and nearly perfect (d > 4.0) (Hopkins et al. 2009). All statistical 
analysis were performed using SPSS (IBM, Statistics, version 23) and level of significance was set 
at p<0.05. 
RESULTS 
No adverse events, injury or complications related to the interventions were seen during the study. 
From those 76 women who started the interventions, 28 were not re-evaluated at follow-up (10 of 
them discontinued the intervention, and 18 were excluded of the analysis due less than 70% of 
minimum adherence established). People who dropped out were more likely to be less educated, 
presented with more co-morbidity, and had a lower cognitive score than those who finished the trial 
(from 23 participants who dropped out: only 34% had completed the primary school, and around 
30.3% had more than five comorbidities, and mean levels of MMSE was 15.6). Details of sample 
drop-out are provided in figure 1. No differences regarding age, anthropometric variables and 
cognitive profile were found among the four groups who completed the trials. According to the 
nursing home menu implemented during the entire study, the mean total calories intake among the 
sample was 1410±370.1, with 58.2±9.2% being carbohydrates, 21.9±4.7% proteins, and 20±7.6% 
fat. No significant differences were found in forearm strength (hand-grip test) in all groups after 
interventions (p>.05). 
Inflammatory markers 
Baseline post-hoc comparisons between those who finished the trial different interventions showed 
that TAU had the lowest values for TNF-α and IL-10 (p<0.05). Table 2 shows the inflammatory 
markers and cognitive changes after the 14 weeks intervention. No significant treatment*time 
interactions were observed for IL-1β and IL-1ra levels over time within the four groups (p<0.05), 
despite a non-significant decrease in CET and TAU groups for IL-1β levels (d=0.6 and d=0.65, 
respectively). Meanwhile, a trend to increase in IL-1ra concentration was observed for the CET 
(d=0.62, p=.06). Taken together, these small changes resulted in a moderate decrease using the IL-
1β/IL-1ra ratio in both the CET and TAU groups (CI 95%: .001 to .16, p=.04, and CI 95%: .036 to 
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.289, p=.01, respectively). Despite no significant treatment*time interactions observed for TNF-α 
levels, univariate analysis showed a moderate decrease in CET (p=.02, d=0.99) and CG (p=.01, 
d=0.68), whereas no significant change was seen in the other groups. Repeated measures ANOVA 
showed a significant treatment*time interaction for changes in IL-10 levels, where a decrease in CG 
was observed (F=12.189, CI 95%: .094 to .351, p=.001), with no significant variations occurring in 
CET, TAU and CET+TAU. Taken together, these changes lead to a significant treatment*time 
interaction in TNF-α/IL-10 ratio (F=4.265, p=.01), where a moderate decrease occurred in the CET 
group (CI 95%: .279 to 1.724, p=.04), and an increase in this ratio was observed for CG (CI 95%: -
1.30 to -.02, p=.01). Plasma IL-6 decreased only in CET (p=0.03), together with a decrease in the 
IL-6/IL10 (CI 95%: .124 to 1.23, p=.02). No significant changes were observed in IL-17 levels for 
all groups between baseline and after 14 weeks (Table 2). 
Cognition: 
Significant time x treatment interactions were observed for MMSE (F=7.49, p<.01), where a 
moderate increase occurred in the CET+TAU group (CI 95%: -3.987 to -.922, p=.04), while a 
decrease in CG score was observed (CI 95%: .616 to 3.550, p=.03). No significant changes were 
observed after CET and TAU interventions (p>.05). 
Peripheral markers of brain damage 
S100β and NSE: None of the interactions reached significance for S100β (F(df: 1, 40)=1.241, 
p=.308). However, adjusted plots of these analyses and univariate tests indicated a trend towards a 
decline in CET (p=.06; d=0.68), and a non-significant elevation in this parameter for controls 
(p=.44) (Figure 2).  
Multivariate stepwise backward regression analyses including the interleukins percent changes and 
baseline co-morbidity showed that there was a trend for changes in IL-1β and CCI to be 
independently associated with changes in S100β. All other variables (IL-1ra, IL-6, TNF-α and IL-
10), were removed in these stepwise backward analyses and did not contribute to the model (Table 
3). Repeated measures ANOVA revealed that there was only a time effect for NSE changes 
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(F=4.182, p=0.04), but no significant treatment*time interactions (p>.05). Univariate comparisons 
showed no significant changes in CET, CET+TAU and CG in comparison to baseline, however, a 
moderate increase in NSE was observed in the TAU group after the 14-week intervention (p=.03, 
d=0.96). 
DISCUSSION 
In this study, we investigated the effects of fourteen weeks of CET and supplementation with 
taurine, alone and combined, on immune parameters and peripheral markers of BBB permeability in 
institutionalized elderly women. Results showed that a CET intervention maintained concentrations 
of peripheral markers for BBB integrity and improved cytokine balance. The same magnitude of 
effect was not observed for the other interventions (except for a large effect of taurine in decreasing 
the IL-1β/IL-1ra ratio). The supplementation with taurine together with exercise did not improve 
the immune parameters in comparison to the interventions alone, but significantly increased 
cognition which was not seen in the other groups. Our observations provide support for the ability 
of exercise to maintain BBB integrity and decrease chronic inflammation in elderly women, which 
might be relevant for public health programs in neurodegenerative disease prevention. As a 
naturalistic study considering preferences of participants for interventions, the study has additional 
value. 
Participants in this study were individuals with average age slightly higher than that in other studies 
with exercise programs for elderly people (Etnier et al. 2006), however, our study was composed 
only by institutionalized elderly women who were supposed to be more debilitated and engaged in 
less physical activity than the community-dwelling population. Despite non-significant, the small 
differences in CCI at baseline between the four groups might be relevant for the magnitude of the 
effect of the interventions tested. It is possible that the exercise in this study was too vigorous for 
individuals with more comorbidities, leading them to attenuate the effort during exercise activities 
while reporting the same perceived exertion. 
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The S100β protein is suggested as a peripheral marker of BBB permeability (Marchi et al. 2003, 
Kanner et al. 2003), being useful and relatively non-invasive for older adults (Mecocci et al. 1995, 
Chaves et al. 2010). Despite also being expressed in other tissues than brain, S100β is present 
primarily in astrocytes, and extracranial sources of this protein do not affect resting serum levels 
(Pham et al. 2010). Over expression of this protein occurs in neurodegenerative conditions, such as 
Alzheimer’s and Parkinson Disease, as well as in traumatic brain injury and schizophrenia, 
situations where BBB permeability is compromised (Steiner et al. 2006, Michetti et al. 2012). 
Given the increasing longevity associated with increased incidence of neurodegenerative disorders, 
an intervention that has the potential to improve the BBB integrity is promising, particularly among 
the elderly population where exercise overall has consistently shown beneficial effects on brain 
function (Hogervorst and Clifford 2012, Northey et al. 2017). 
The mechanism by which long-term exercise can maintain the permeability of the BBB in humans 
is still subject of debate, and until today the few studies investigating this were done using animal 
models. Guo and co-workers (Guo et al. 2008) pointed out that exercise could improve the BBB 
structure by ameliorating the integrity of the basal lamina, in association with a decreased 
expression of matrix-metalloproteinase-9. Exercise was also found to protect the striatal BBB in an 
animal model of diabetes (de Senna et al. 2015). The results of our study corroborate other findings 
where exercise produced an immunomodulatory effect, by reducing the pro-inflammatory and 
increasing the anti-inflammatory cytokines (Souza et al. 2016). Production of TNF-α directly 
affects the BBB permeability (Larochelle et al. 2011). Evidence has shown that physical exercise 
inhibited the production of pro-inflammatory cytokines, upregulated the regulatory T cells, and 
suppressed IL-6 and TNF-α production associated with the inhibition of adhesion molecules and re-
establishment of tight junction protein expression, thereby restraining BBB permeability (Mota et 
al. 2012, Souza et al. 2016). Our exercise results clearly showed a decrease in the IL-1β/IL-1ra, IL-
6/IL10 and TNF-α/IL-10 ratios. Thus, one can put forward the hypothesis that these effects could 
contribute to the decrease in S100β after the intervention. Other mechanisms by which exercise can 
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ameliorate the BBB integrity could be due to the modulatory redox status of sensitive small 
GTPase, an enzyme that is activated by rho kinase (Wolff et al. 2014). Activation of rho GTPases is 
related to the decrease in the expression of proteins from tight junction (such as claudin-5), and 
increase in BBB permeability through monocyte migration (Persidsky et al. 2006). Evidence has 
demonstrated that exercising mice had less activation of rho kinase than sedentary animals, 
supporting the idea that exercise practice could maintain the BBB integrity through these 
mechanisms (Wolff et al. 2015). 
The anti-inflammatory and antioxidant effect of taurine might explain a slight decrease in S100β 
after interventions in supplemented groups. Myeloperoxidase can derivate production of 
hypochlorous acid (HOCl-) as a oxidative species and has previously been related to BBB 
breakdown (Üllen et al. 2013). Supplementation with taurine can abolish the formation of HOCl- 
(Marcinkiewicz and Kontny 2014). It is thus plausible that ingestion of taurine for 14 weeks 
suppressed the MPO-oxidative pathway and contributed to maintain BBB integrity, beyond its 
potential to increase anti-inflammatory cytokines. Considering this result, it seems clear that one of 
the most important mechanisms by which both exercise and taurine can act on BBB integrity is via 
an immunomodulatory and antioxidant pathway. Indeed, in response to the intervention protocols, 
we explored the relationship between changes in cytokines and S100β over time. Our results 
demonstrated that group membership determined changes between interventions and controls in this 
parameter, while there was also a trend for baseline CCI and change in IL-1β to be independently 
associated with change in S100β. Despite not inferential, this result suggests the possibility that 
fluctuations in BBB integrity may be related to modulation of inflammatory cytokines, which is 
consistent to those investigations in animal model mentioned above (Mota et al. 2012, Souza et al. 
2016). 
Taurine, is essential to the normal growth and development of the nervous system, being related to 
neurogenesis, differentiation and neuroprotection (Gebara et al. 2015). The NSE in brain, is 
involved in the same processes, including maturation of neuronal cells (Isgrò et al. 2015). Since 
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taurine can be transported across the BBB through B-amino acid transporter, it could induce 
neurotrophic factors by increasing the expression of NSE (Liu et al. 2013). It’s plausible that an 
increased CNS formation of NSE induced by taurine could lead to an augmented efflux to 
peripheral circulation, increasing their serum levels as observed in TAU group. However, this 
mechanism need to be further exploited in humans. 
Regarding differences in TNF-α, IL-10 and TNF-α/IL-10 ratio, it seems that exercise is more likely 
to induce an anti-inflammatory environment rather than decrease inflammatory cytokine 
production. In fact, previous data with elderly individuals showed that twenty-eight weeks of 
exercise intervention was more effective in increasing IL-10 levels rather than decreasing TNF-α 
levels (Chupel et al. 2017). This effect may be mediated by an increase of production and release of 
anti-inflammatory cytokines by the repeated bouts of exercise from muscle (myokines), or reduced 
expression of Toll-like receptors in monocytes and macrophages (Gleeson et al. 2011). Meanwhile, 
groups who did not engage in exercise (TAU and CG) tended to show reduced IL-10 values over 
time. The mechanism by which exercise training decreased IL-6 concentration is generally 
attributed to a reduction in fat mass and/or via decrease formation of pro-inflammatory cytokines 
from peripheral mononuclear (PMN) cells. Since adipose tissue is a source of circulating IL-6, a 
reduction in fat mass could led to a decreased release of this cytokine into the blood (Gleeson et al. 
2011). However, our intervention did not reduce the body mass in all groups, making unlikely that 
the reduction observed could be attributed to loss of fat mass alone. Since decreases in IL-1β/IL-
1ra, IL-6/IL-10 and TNF-α/IL-10 ratios were observed in CET, its plausible to think that reduction 
in IL-6 was influenced mainly by decreased cytokine production by PMN, which is consistent with 
other studies with elderly individuals (Kohut et al. 2006). 
Results also showed that the combination of exercise and taurine promoted major responses in 
global cognition. When exercise or taurine supplementation were applied by themselves, 
maintenance of cognitive levels occurred and there were no significant changes. In contrast, 
cognitive function in CG declined after care as usual. The effects of exercise on global cognition 
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have been previously reviewed, and  generally implementation of several exercise programs have 
shown improvement in overall cognition (Hogervorst and Clifford 2012). However, different types 
of exercise and adherence, as well as the baseline cognitive level of the participants, may have 
introduced bias (Etnier et al. 2006). Effects of exercise were most strongly seen in elderly women 
(Hogervorst and Clifford 2012) which could explain the results of the present study which did not 
include men. 
The mechanisms by which exercise improves cognition are many, and ranges from improvements in 
immunity (Stranahan et al. 2012), and/or inducing neurotrophic factors (Intlekofer and Cotman 
2013). As mentioned, the groups where improved cognition occurred presented simultaneously with 
a better immune balance, which might explain why the effect on cognition was strongest in the 
combined treatment arm. A recent study has showed interaction between peripheral immunity and 
the CNS through the BBB, elucidating the fact that a decrease in blood pro-inflammatory cytokine 
could result in maintenance (or even, increase), of cognition (Engelhardt et al. 2017, Bradburn et al. 
2018). 
In animal models, taurine has been shown to protect or even improve cognition (Vohra and Hui 
2000). Analogues of taurine such as homotaurine, have been proposed for therapeutic applications 
due its anti-amyloid activity (Caltagirone et al. 2012). This effect might be relevant for treatment of 
severe cognitive impairment, such as Alzheimer Disease. Due the similarity with GABA, taurine is 
known to act as an inhibitory neurotransmitter and neuromodulator (Ripps and Shen 2012). This 
involvement may explain the significance of taurine on cognitive function, since GABA influences 
cognition (Gabriella and Giovanna 2010). The importance of supplementation with taurine in the 
elderly could be explained due to the age-dependent reduction in levels. Even in healthy elderly 
there is a 49% decrease in plasma taurine concentration in comparison with middle-aged individuals 
(Jeevanandam et al. 1990), which may justify supplementation in elderly populations. Although 
physiological levels of taurine achieved by supplementation could generate several neuroendocrine 
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responses in the healthy brain, further research is needed to investigate its effect in pathological 
conditions. 
CONCLUSION 
Despite some limitations (such as a small sample size), there are several important issues addressed 
by this naturalistic study. Firstly, our study suggests that exercise could help prevent the BBB 
leakage, even in advanced age. Secondly, this effect - at least in part, is probably mediated by 
immune changes, but this mechanism needs to be further investigated. In addition, taurine 
demonstrated small beneficial effects, but appears to be important as an auxiliary nutritional 
supplement to exercise to improve cognition in institutionalized elderly women. 
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TABLES 
Table 1. Participants characteristics at baseline 
Groups Age (years) Height (cm) Weight (Kg) BMI (Kg/m2) Systolic BP (mmHg) 
Diastolic BP 
(mmHg) 
CCI 
CET (n=13) 83.5(7.3) 155.4(6.0) 65.2(11.3) 27.2(3.8) 140.9(19.8) 69.7(12.6) 6.6(1.5) 
TAU (n=12) 85(4.5) 157.7(7.4) 71(11.3) 27.1(3.2) 139.9(18.8) 72.4(8.1) 6.8(0.9) 
CET+TAU (n=11) 83.8(8.6) 150.5(2.8) 62.6(9.5) 28.1(4.5) 139.5(13.5) 64.3(13.2) 7(1.7) 
CG (n=12) 82(7.5) 151.9(7.5) 67.3(13.5) 30.3(3.5) 133.6(26.6) 66.1(7.1) 8.4(2.7) 
Values are expressed in mean(SD). CET: combined exercise training; TAU: taurine supplementation; CET+TAU: combined exercise training + taurine 
supplementation; CG: control group; BMI: body mass index, BP: blood pressure, CCI: Charlson Comorbidity Index (score). 
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Table 2. Cytokines and cognitive changes. 
Groups Baseline After 14-weeks Effects F Overall pa pb (0 to 14-weeks) ESc 
IL-1β (pg/mL) 
CET 4.5(1.2) 4.0(0.3) 0.142 0.60 
TAU 4.0(0.2) 3.8(0.5) Time 2.905 0.096 0.128 0.65 
CET+TAU 4.3(0.4) 4.3(0.5) Time*group 0.663 0.580 0.656 0.19 
CG 4.6(0.9) 4.2(0.6) 0.48 0.29 
IL-1ra (pg/mL) 
CET 26.3(13.6) 35.1(13.7) 0.067 0.62 
TAU 29.1(19.3) 28.0(10.0) Time 3.443 0.070 0.742 0.36 
CET+TAU 25.6(16.0) 24.9(8.1) Time*group 1.113 0.354 0.51 0.04 
CG 26.8(12.9) 28.4(10.2) 0.719 0.26 
IL-1β/IL-1ra ratio 
CET 0.2(0.1) 0.1(0.0) 0.047 0.88 
TAU 0.3(0.1) 0.1(0.0) Time 10.487 0.002 0.016 1.00 
CET+TAU 0.2(0.1) 0.1(0.0) Time*group 2.560 0.067 0.286 0.23 
CG 0.2(0.1) 0.2(0.2) 0.995 0.26 
TNF-α (pg/mL) 
CET 12.8(7.5) 9.7(3.9) 0.038 0.99 
TAU 8.6(6.4) 7.7(5.2) Time 2.067 0.158 0.452 0.57 
CET+TAU 16.8(8.1) 18.3(6.9) Time*group 2.238 0.097 0.383 0.27 
CG 12.8(5.6) 9.6(3.7) 0.094 0.68 
IL-10 (pg/mL) 
CET 3.0(1.9) 3.3(1.9) 0.641 0.07 
TAU 2.2(1.1)# 2.0(1.1) Time 2.837 0.099 0.289 0.32 
CET+TAU 3.5(1.1) 3.5(0.7) Time*group 3.470 0.024 0.711 0.11 
CG 4.4(1.6) 2.2(1.5) 0.01 1.30 
TNF/IL-10 ratio 
CET 4.6(1.6)# 3.6(1.7) 0.039 0.85 
TAU 3.6(1.3) 4.0(1.6) Time 0.307 0.583 0.374 0.43 
CET+TAU 4.6(1.7)# 5.1(1.3) Time*group 4.265 0.010 0.310 0.51 
CG 3.1(1.5) 3.7(1.5) 0.042 1.14 
IL-6 (pg/mL) 
CET 7.0(5.4) 4.9(5.7) 0.036 0.76 
TAU 4.4(2.2) 4.4(2.5) Time 2.669 0.109 0.619 0.04 
CET+TAU 8.6(10.2) 8.6(7.7) Time*group 2.521 0.07 0.227 0.27 
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CG 7.7(9.4) 4.4(2.0) 0.298 0.50 
IL-6/IL-10 ratio 
CET 2.0(1.1) 1.3(1.0) 0.02 1.11 
TAU 2.5(1.8) 2.8(2.3) Time 0.003 0.954 0.340 0.43 
CET+TAU 2.5(3.4) 2.4(2.1) Time*group 1.414 0.251 0.841 0.64 
CG 1.7(1.6) 2.3(2.9) 0.478 0.43 
IL-17 (pg/mL) 
CET 10.3(6.4)# 9.1(4.6) 0.507 0.26 
TAU 17.8(9.6) 14.9(6.5) Time 0.705 0.406 0.238 0.50 
CET+TAU 17.4(10.7) 16.3(12.2) Time*group 0.269 0.848 0.789 0.11 
CG 18.4(12.4) 19.0(13.5) 0.638 0.19 
MMSE (score) 
CET 20.2(5.8) 21.7(5.0) 0.109 0.64 
TAU 18.6(5.8) 18.2(5.8) Time 0.943 0.337 0.318 0.43 
CET+TAU 21.3(4.5) 23.8(3.6) Time*group 7.490 0.000 0.016 1.06 
CG 19.4(6.3) 17.3(4.9) 0.015 0.98 
Values are presented in Mean(SD); a Two-sided significance of differences across time and between the groups (repeated measures ANOVA); b Two-sided 
significance of within differences between baseline and 14-week assessments (paired t-test); c Within effect size represented by Cohen’s d for changes in means; # 
Different from control group at baseline; Values of significance (p<0.05) are highlighted in bold. 
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Table 3. Multiple regression analysis for changes in S100β
∆S100β 
R2 β coefficient p value p ANOVA 
∆IL-1β 
0.163 
.278 .056 
.048 ∆IL-17 .205 .162 
CCI baseline .259 .076 
Note: unadjusted backward multiple regression analysis; changes in other cytokines (IL-6, IL-10, 
TNF-α, and IL-1ra) did not contribute to the model and were removed in this analysis. 
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FIGURE CAPTIONS 
Figure 1. CONSORT (Consolidated Standards of Reporting Trials) of the study design. CET: 
combined exercise training; TAU: taurine supplementation; CET+TAU: combined exercise training 
plus taurine supplementation; CG: control group 
Figure 2. A) S100β; B) Neuronal-specific enolase (NSE); Lines represented means with standard 
error bars. With black lines: CET= combined exercise training; TAU= taurine supplementation; 
CET+TAU= combined exercise training plus taurine supplementation; With grey line: CG= control 
group; T0: baseline; T1: after 14 weeks; * p<0.05 
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A) S100β; B) Neuronal-specific enolase (NSE); Lines represented means with standard error bars. With
black lines: CET= combined exercise training; TAU= taurine supplementation; CET+TAU= combined
exercise training plus taurine supplementation; With grey line: CG= control group; T0: baseline; T1: after 
14 weeks; * p<0.05 
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